- Home
- PHAT vs ULH Comparison
PHAT vs ULH Comparison
Compare PHAT & ULH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- ULH
- Stock Information
- Founded
- PHAT 2018
- ULH 1932
- Country
- PHAT United States
- ULH United States
- Employees
- PHAT N/A
- ULH N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- ULH Trucking Freight/Courier Services
- Sector
- PHAT Health Care
- ULH Industrials
- Exchange
- PHAT Nasdaq
- ULH Nasdaq
- Market Cap
- PHAT 716.5M
- ULH 635.2M
- IPO Year
- PHAT 2019
- ULH 2005
- Fundamental
- Price
- PHAT $11.91
- ULH $27.14
- Analyst Decision
- PHAT Strong Buy
- ULH Hold
- Analyst Count
- PHAT 5
- ULH 1
- Target Price
- PHAT $16.40
- ULH $29.00
- AVG Volume (30 Days)
- PHAT 1.1M
- ULH 31.5K
- Earning Date
- PHAT 08-07-2025
- ULH 07-24-2025
- Dividend Yield
- PHAT N/A
- ULH 1.54%
- EPS Growth
- PHAT N/A
- ULH N/A
- EPS
- PHAT N/A
- ULH 2.31
- Revenue
- PHAT $114,039,000.00
- ULH $1,668,148,000.00
- Revenue This Year
- PHAT $194.40
- ULH N/A
- Revenue Next Year
- PHAT $103.23
- ULH $7.88
- P/E Ratio
- PHAT N/A
- ULH $11.77
- Revenue Growth
- PHAT 1049.82
- ULH N/A
- 52 Week Low
- PHAT $2.21
- ULH $20.60
- 52 Week High
- PHAT $19.71
- ULH $53.29
- Technical
- Relative Strength Index (RSI)
- PHAT 75.25
- ULH 59.51
- Support Level
- PHAT $9.82
- ULH $23.66
- Resistance Level
- PHAT $11.19
- ULH $25.52
- Average True Range (ATR)
- PHAT 0.71
- ULH 1.07
- MACD
- PHAT 0.17
- ULH 0.24
- Stochastic Oscillator
- PHAT 94.07
- ULH 98.67
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.